ChristianaCare Becomes First in Delaware to Offer CAR-T Therapy for Advanced Multiple Myeloma

New treatment gives patients a powerful new option when other therapies stop working

Jun 5, 2025

3 min

Thomas Schwaab, M.D., PH.D.

ChristianaCare’s Helen F. Graham Cancer Center & Research Institute is the first in Delaware to offer a powerful new tool in the fight against multiple myeloma—a type of blood cancer that affects plasma cells in the bone marrow. That tool is a new chimeric antigen receptor (CAR) T-cell therapy, called CARVYKTI, which can improve treatment for adults with multiple myeloma that has returned or stopped responding to other treatments.


“CAR-T cell therapy represents a paradigm shift in the treatment of multiple myeloma,” said Thomas Schwaab, M.D., Ph.D., Bank of America Endowed Medical Director of the Helen F. Graham Cancer Center & Research Institute." We are expanding access to this life-extending therapy right here in Delaware — close to home, close to hope. This is part of our ongoing commitment at the Graham Cancer Center to ensure our community has access to the most advanced cancer therapies.”



Multiple myeloma is a relatively rare cancer, but it still affects a significant number of people each year. In the United States, it is estimated that around 36,110 new cases will be diagnosed in 2025, according to the American Cancer Society


What is CAR-T Therapy?


CAR-T cell therapy uses a patient’s own immune cells to fight cancer. Doctors first collect the patient’s T cells, which are a type of white blood cell that helps the body fight infections. In the lab, these T cells are reprogrammed by adding a special receptor called a chimeric antigen receptor (CAR). This receptor allows the T cells to recognize specific proteins on cancer cells, acting like a navigation system to help the T cells find and attack the cancer.


After this genetic modification, the reprogrammed T cells are expanded in the lab to create a larger army of cancer-fighting cells. Then, they are infused back into the patient’s body, where they go on to find and destroy the cancer cells. This therapy is approved for adults who have already tried several standard treatments, like proteasome inhibitors, immunomodulators and anti-CD38 antibodies, without success. When those treatments stop working, CARVYKTI can offer a powerful new option.



CAR T-cell therapy has given new hope to patients with multiple myeloma whose cancer has returned or stopped responding to other treatments. Many people see their cancer shrink or even disappear for a period of time, which can help them live longer and feel better. While the treatment can have short-term side effects, many patients report feeling stronger and having fewer symptoms once they recover. It’s not a cure, but for some, it can mean more time with loved ones and a better quality of life.


“This therapy gives our patients a chance when other treatments have failed,” said Zhifu Xiang, M.D., medical oncologist at ChristianaCare Oncology Hematology. “It’s a deeply personalized approach that uses the patient’s own immune system to fight the cancer in a powerful new way. Being able to offer this locally means our patients don’t have to travel far for world-class care.”



A Leader in Cell Therapy


The Graham Cancer Center’s dedicated team of specialists have been offering CAR-T cell therapy for other cancer types, such as lymphoma and leukemia, since 2018. The center is also recognized by the Foundation for the Accreditation of Cellular Therapy (FACT) for meeting the highest standards in safety, quality and patient care.


To learn more about CAR-T cell therapy or other cancer treatments at ChristianaCare, visit christianacare.org/cancer or call the Helen F. Graham Cancer Center & Research Institute at 302-733-HOPE (4673).




Connect with:
Thomas Schwaab, M.D., PH.D.

Thomas Schwaab, M.D., PH.D.

Bank of America Endowed Medical Director, Helen F. Graham Cancer Center & Research Institute

Nationally recognized urologic surgeon and leader of strategic development

ImmunologyTranslational Cancer ResearchUrologic OncologyBusiness Development

You might also like...

Check out some other posts from ChristianaCare

1 min

ChristianaCare Appoints Ashley Panichelli, M.D., Vice Chair, Department of Family and Community Medicine

Ashley Panichelli, M.D., has been appointed vice chair of the Department of Family and Community Medicine at ChristianaCare. In this role, Panichelli will support the department’s clinical and academic missions. She will help guide quality and safety initiatives and promote a culture of accountability, learning and psychological safety. She will advance education and professional development across faculty and residency programs, assist with strategic planning, mentorship and peer review, and strengthen collaboration across department leadership, faculty and staff. A Delaware native, Panichelli earned her medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and completed her residency and chief residency in Family Medicine at ChristianaCare in 2018. She joined the residency program’s core faculty that same year and has since held several leadership roles, including clinical lead and associate program director. In 2022, she was named clinical director of Academic and Complex Primary Care, a role she continues to support. Panichelli is a clinical assistant professor at Sidney Kimmel Medical College and has been recognized with several honors, including the Delaware Academy of Family Physicians’ Teacher of the Year award and the Department’s Rising Star award. She completed ChristianaCare’s ACT course, the LEED-R elective, and the Harvard Medical Director Leadership Institute. She was an Emerging Leaders Institute scholar with the American Academy of Family Physicians Foundation. She reports to Erin Kavanaugh, M.D., FAAFP, chair of the Department of Family and Community Medicine.

3 min

Delaware INBRE Summer Scholars Complete Biomedical Research Projects at ChristianaCare

Eight undergraduate scholars recently completed a 10-week immersion in biomedical research through the Delaware IDeA Network of Biomedical Research Excellence (INBRE) Summer Scholars Program at ChristianaCare. Their projects, spanning oncology, emergency medicine and community health, culminated in a capstone presentation and celebration on August 13 at Christiana Hospital. This year’s cohort included students from University of Delaware, Delaware State University and Delaware Technical Community College, as well as Delaware residents attending college out of state. Each student was paired with expert mentors from across ChristianaCare, contributing to research designed to improve patient care and outcomes. In addition to their primary projects, the scholars explored ChristianaCare’s advanced facilities such as the Gene Editing Institute Learning Lab, gaining hands-on exposure to cutting-edge methods in biomedical research. “This year’s DE-INBRE program at ChristianaCare was a one-of-a-kind experience,” said Susan Smith, Ph.D., RN, program director of Technology Research & Education at ChristianaCare and the INBRE site principal investigator. “We brought together undergraduates from various academic backgrounds and immersed them in real, hands-on biomedical research with some of our most accomplished investigators. “Watching these students go from a little unsure on day one to confidently presenting their own findings by the end of the summer was inspiring, and proof that programs like this are building the next generation of biomedical researchers in Delaware.” Delaware INBRE is a statewide initiative funded by the National Institutes of Health to strengthen Delaware’s biomedical research infrastructure. It supports undergraduate research training, faculty development and core facility investments across partner institutions. At ChristianaCare, the program offers students immersive, hands-on research experiences guided by seasoned investigators, equipping them with the skills, mentorship and exposure essential for careers in science and medicine. Madeline Rowland, a Delaware resident and rising senior at Williams College in Massachusetts, collaborated with Hank Chen, senior medical physicist at the Helen F. Graham Cancer Center & Research Institute, to evaluate tattoo-free, surface-guided radiation therapy for breast cancer patients. She also worked with leaders of ChristianaCare’s Center for Virtual Health to explore how different patient populations experience virtual primary care. Rowland praised the program for the research skills and knowledge she gained as well as the meaningful relationships she built with mentors, health care professionals and fellow scholars she might not have otherwise met. “Dr. Chen and the whole Radiation team really adopted me into the department,” Rowland said. “From sitting on the CT simulation table in my first week to working on my project, I felt fully welcomed. I’ve learned so much, and the people I’ve met made this summer unforgettable.” Chen was recognized as the program’s inaugural “Mentor of the Summer” for his exceptional dedication and thoughtful approach to teaching. Having now mentored INBRE scholars for three years, Chen has a personal connection to the program. His own daughter participated as an undergraduate and recently began her general surgery residency after graduating from Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia. For Chen, mentoring represents an investment in health care’s future. “The greatest asset of any institution is its talent,” he explained. “When you welcome students into your environment, you draw good people to your field, and patients ultimately benefit from that.” Naana Twusami, a rising senior at Delaware State University, spent her summer with the Oral & Maxillofacial Surgery and Hospital Dentistry Department. She examined social determinants of health in facial trauma patients, analyzing how factors like income, education, transportation and insurance status influence recovery. “Being here showed me that things like income or transportation can matter just as much as the medical care itself,” she said. “The INBRE Summer Scholars Program gave me a real look at how health care works, and how places like ChristianaCare are helping shape where it’s headed.” Amy Minsker, continuing medical education manager, Academic Affairs, served as manager of the summer scholars program. Read more on news.christianacare.org.

3 min

Jennifer Oldham of ChristianaCare Champions Life-Saving CPR Care

“Whether you’re a brother or whether you’re a mother/ You’re stayin’ alive, stayin’ alive.” Nearly 50 years since this song’s debut, the faint symphony of the Bees Gees’ “Stayin’ Alive” can be still heard around the world, though not only through an ordinary radio or Bluetooth speaker. Some people, like Jennifer Oldham, MSN, RN, CEN, AACC, play the tune in their thoughts when giving and demonstrating rhythmic CPR compressions. The song’s tempo serves as guidance to match the timing of CPR chest compressions. Oldham, a cardiovascular quality and innovation nurse program manager at ChristianaCare’s Center for Heart & Vascular Health, has dedicated the last three decades to teaching others about harnessing the power of CPR to save patients and loved ones. She knows firsthand the miracles CPR can produce. Knowledge is power Community members, health care professionals and students have the ability to save a life thanks to Oldham. She’s conducted dozens of classes and lectures to give nurses and bystanders the tools and confidence to perform CPR in an emergency. Her profound work recently earned her an honor at the American Heart Association’s Delaware Heart Ball. The Heart Association recognized four individuals representing four key tenets or “chambers” — “discovery, advocacy, equity, and knowledge.” Oldham was chosen as the honoree for the Knowledge Chamber for her dedication to empowering others with life-saving education and tools. “Jen Oldham’s work is the heartbeat of our Knowledge Chamber. Her dedication to CPR education reflects the very mission of the American Heart Association – to ensure more lives are saved through awareness and action,” said Ellen Vild, director of the Delaware Heart Ball. “Jen’s story reminds us that knowledge is power, but more importantly, it’s compassion in action. We are honored to recognize her as someone who lives that mission every single day.” Oldham’s colleague Neil Wimmer, M.D., MS, interventional cardiologist and medical director of the Cardiac Catheterization Laboratory, was delighted to see her recognized. “Jen is an amazing colleague and friend who is driven by compassion and empathy. She makes everyone in our state safer, whether they know it or not,” Wimmer said. The gift of life To Oldham, teaching others about CPR is rewarding. She makes a meaningful impact on patients’ lives every day through care, education, emotional support and community connection. CPR is more than just a technique, she said: It’s a lifechanging bond. “In my opinion, performing CPR is one of the most kind and loving acts one person can do for another. It is incredibly intimate … laying hands on someone’s chest and pushing, circulating their blood to save their life,” Oldham said. “What a beautiful gift to give someone — the gift of life, the gift of more time with their loved one.” Walking to save lives The ChristianaCare team and Oldham support heart health as part of the annual Wilmington Heart Walk. Last year they raised over $42,000 for the American Heart Association to fund research and education to help Americans live longer, healthier lives. Oldham has been a co-chair of the event since 2017 and is a strong advocate of the AHA’s mission. Valerie Dechant, M.D., MBA, FACP, chief medical officer of Christiana Hospital, knows the value of Oldham’s efforts in the community. “Jen’s passion for educating the public about acute cardiac emergencies is unmatched,” she said. “With decades of experience and a remarkable ability to translate clinical expertise into clear actionable knowledge, she empowers others to learn to feel confident and prepared in a crisis.”

View all posts